30.11.2021
В. А. Головачева; А. А. Головачева
Patients with COVID-19 may develop various neurological disorders of the central and peripheral
30.11.2021
Е. В. Попова
the outbreak of the COVID-19 pandemic caused by a novel coronavirus SARS-CoV-2. Immunosuppressive drugs were
30.11.2021
Б. С. Белов; Н. В. Муравьева; М. М. Баранова
infections, viral hepatitis B, yellow fever and COVID-19 used in rheumatological patients. It has been shown
30.11.2021
Н. В. Орлова; В. В. Ломайчиков
of complications. In the context of the COVID-19 pandemic, there is a possibility of simultaneous circulation
29.11.2021
Т. Ю. Владимирова; Л. А. Барышевская; А. В. Куренков
Introduction. One of the characteristic manifestations of COVID-19 is a disorder of smell, which
31.10.2021
А. А. Гирина; А. Л. Заплатников; Е. И. Бурцева; В. И. Свинцицкая; И. Д. Майкова; Н. Ф. Дубовец; Н. В. Короид; И. В. Леписева; A. Е. Voskanyan; А. Э. Восканян; Д. Н. Ткачева; А. Д. Панова; С. А. Моторный
. Attention is paid to the need during the ongoing pandemic COVID-19 to fully immunize children as part
30.10.2021
Е. М. Костина; Е. Ю. Трушина; Е. А. Орлова
of the most common diseases of respiratory system. In 2019, the coronavirus infection (COVID-19) pandemic
30.10.2021
Н. Б. Лазарева
importance. COVID-19, along with influenza, is a group of respiratory viral infections, but important
30.10.2021
В. П. Золотницкая; О. Н. Титова; Н. А. Кузубова; А. П. Литвинов
in microcirculation in the lungs of patients with COVID-19 infection, since CT angiography can detect these formidable
30.10.2021
К. И. Карноух; Н. Б. Лазарева
to patients hospitalized with COVID-19 is many times higher than the level of bacterial infection recorded
